27 Feb 2020
Prof. Kevin Eggan, Harvard Stem Cell Institute, shares how ensemble experiments using single-cell sequencing technologies are helping elucidate the pathway changes in psychiatric conditions like schizophrenia. Hear about the latest trends in stem cell technologies and how these are starting to be translated to new therapeutics and cures for diseases.
Harvard University
Prof. Kevin Eggan, Professor, Department of Stem Cell and Regenerative Biology at Harvard Institute, Member, Harvard Stem Cell Institute, and Institute Member of the Broad Institute of Harvard and MIT